Cycloferon

Roman name

Cycloferonum

The composition and the form of

1 ml solution for injection acid akridonuxusna (the main active component) 0,125 g N-metilglukamina (soleobrazutaya and stabilizing additive) 0.0963 g water for injection; in ampoule 2 ml, in a Box 5 vials.

Characteristics

Low interferon inducer.

Of drugs

Immunostimulating, antiviral, противовоспалительно е.

Farmakodinamika

Normalizes the immune status organism produces a interferon with immunodeficiency conditions and autoimmune diseases.

Indications

The adults (in the complex therapy), HIV (AIDS IIA-IIIB stage), CNS (serous meningitis, encephalitis, Lyme disease), viral hepatitis (A, B, C, D), faster, and zitomegalovirusne hlamidiynye infection secondary immunodefitsitnye state in the face of chronic bacterial and fungal infections, rheumatic and systemic diseases of connective tissue (rheumatoid arthritis, systemic lupus red), �егенеративно-дистроф ические of the joints, including distortive Osteoartroz.u children over 4 years (as part of an integrated treatment), viral hepatitis (A, B, C, D, GP), and herpes infection.

Pregnancy and lactation

Contraindicated in pregnancy. At the time of treatment should stop breastfeeding.

Contraindications

Hypersensitivity, decompensirovanny cirrhosis, pregnancy, breast-feeding, age up to four years.

Side-Effects

Allergic reactions.

Specific guidance

Treatment gerpeticakih and cytomegalovirus infections most effectively in the early stages of the disease.

Patient interaction

Compatible with other property used in the treatment referred to in the testimony of diseases (interference, chemotherapy LAN, etc.).

Precautions

In Thyroid diseases treatment should be carried out under the supervision of an endocrinologist.

Dosing and Administration

Adults : in / m, / V.virusny hepatitis-time dose of 0.25 g once a day treatment injection 5 (the first two-day, and then one day); Dose rate - 1.25 g second course with 10-14 Dnei.gerpeticskie and zitomegalovirusne infection-10 injection of 0.25 g, the first two-day, then through Deny.neiroinfection-12 injection of 0.25 g per 1, 2, 4, 6, 8, 11, 14, 17, 20, 23, 26, the 29th day, coupled with etiotropona therapy (dose rate 3 g, refresher courses, as �еобходимости).Хламид��оз 0.25 g once a day treatment injection 5 (the first two-day, and then one day), in combination with antibiotics; dose rate - 1.25 g second course with 10-14 Dnei.vic-infectia (AIDS, the stage IIA-IIIB) in / m, 7 injection of 0.5 g (the first two-day, then one day), dose rate 3.5 g, and then maintenance treatment on 0.5 g every five days during 2.5 months; re-appoint course after one of Mes.immunodefitsitnye in / m, 7 injection of 0.25 g once a day, every other day, dose rate 1.75 g re-rate a six Mes.revmaticalkie and systemic diseases connective tissue of 4 to 5 injections (at 0.25 g), with an 10 to 14 days may prevent full course on the recommendation of �рача.Дегенеративно-д��строфические diseases of joints-2 rate to 5 injections (at 0.25 g), with an 10 to 14 days (possibly for a run-rate). Children : in the / m or / as, once a day, daily intake at the rate of 6-10 mg / Kg.ostry viral hepatitis (A, B, C, D, GP and mixed) - 15 injection at 1, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, the 28th day, the protracted period repetition of a 10-14 Dnei.hroniceski viral hepatitis (B, C, D, GP), a product introduced at 1, 2, 4, 6, 8, 10, 12, 14, 16, the 18th day, Further maintenance treatment once every five days during the three months while maintaining replikativna and zitoliticescoy activity Processa.vic-infectia disorder, chronic viral hepatitis C-10 injection at 1, 2, 4, 6, 8, 10, 12, 14, 16, 18th day, and continue to support the scheme - one every five days for three months while maintaining replikativna and zitoliticescoy activity pathological process in chronic Hepatitis C, mixed forms of hepatitis and HIV infection rate supports can be extended up to six Mes.gerpetical infection, a product introduced at 1, 2, 4, 6, 8, 11, 14, 17, 20 and 23rd day; while maintaining the activity replikativna virus treatment to continue supporting pattern : one every five days for four weeks.

Directory → Immunotropona funds → Immunomodulators → Cycloferon